The impact of policy changes on the sales of the environmentally harmful drug diclofenac in Sweden
Open Access
- 11 October 2025
- journal article
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 34 (2) , 212-215
Abstract
Objectives: In Sweden, oral formulations of diclofenac became prescription-only in 2020, and over the counter (OTC) topical forms were placed behind the counter in 2023. This study investigated the effect of these policy changes on diclofenac dispensed or sold. Methods: Aggregated data on diclofenac dispensed against prescription or sold OTC from January 2019 to February 2024 were analysed descriptively. Key findings: The volume fell substantially after oral formulations became prescription-only. Placement of topical formulations behind the counter had a more modest effect. Conclusions: Policy changes have had a significant effect on the volume of diclofenac dispensed or sold in Sweden, especially the prescription requirement.Keywords
Funding Information
- Sahlgrenska Academy, University of Gothenburg
This publication has 8 references indexed in Scilit:
- Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislationThe Lancet Planetary Health, 2024
- Transformation products of diclofenac: Formation, occurrence, and toxicity implication in the aquatic environmentWater Research, 2024
- Estimating environmental exposure to analgesic drugs: A cross-sectional study of drug utilization patterns in the area surrounding Sweden's largest drinking water sourceEnvironmental Advances, 2023
- Preferences for medicines with different environmental impact – A Swedish population-based studyEnvironmental Advances, 2023
- Naproxen affects multiple organs in fish but is still an environmentally better alternative to diclofenacAquatic Toxicology, 2020
- Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The NetherlandsPharmacoepidemiology and Drug Safety, 2020
- Balancing the health benefits and environmental risks of pharmaceuticals: Diclofenac as an exampleEnvironment International, 2015
- Diclofenac residues as the cause of vulture population decline in PakistanNature, 2004